Fonte: International Immunopharmacology. Unidade: FMRP
Assuntos: NEUTRÓFILOS (FISIOLOGIA), FAGOCITOSE (EFEITOS DE DROGAS), LECTINAS (METABOLISMO), PROTEÍNAS RECOMBINANTES (FARMACOLOGIA)
ABNT
MARCHI, Larissa Fávaro et al. In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. International Immunopharmacology, v. 18, n. 2, p. 228–235, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2013.12.010. Acesso em: 26 ago. 2024.APA
Marchi, L. F., Sesti-Costa, R., Ignacchiti, M. D. C., Silva, S. C., & Mantovani, B. (2014). In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. International Immunopharmacology, 18( 2), 228–235. doi:10.1016/j.intimp.2013.12.010NLM
Marchi LF, Sesti-Costa R, Ignacchiti MDC, Silva SC, Mantovani B. In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines [Internet]. International Immunopharmacology. 2014 ; 18( 2): 228–235.[citado 2024 ago. 26 ] Available from: https://doi.org/10.1016/j.intimp.2013.12.010Vancouver
Marchi LF, Sesti-Costa R, Ignacchiti MDC, Silva SC, Mantovani B. In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines [Internet]. International Immunopharmacology. 2014 ; 18( 2): 228–235.[citado 2024 ago. 26 ] Available from: https://doi.org/10.1016/j.intimp.2013.12.010